Medpace Holdings, Inc. (MEDP)

387.75 -0.60 (-0.15%) As of 11:56AM EDT. Market open.

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 5,800

Key executives

Name	Title	Pay	Exercised	Year born
Dr. August James Troendle M.D.	Chairman & CEO	1.65M	N/A	1956
Mr. Jesse J. Geiger BBA, CPA	President	945.08k	N/A	1974
Mr. Kevin M. Brady	CFO & Treasurer	690.48k	1.64M	1975
Ms. Susan E. Burwig BSN, MA	Executive Vice President of Operations	1.12M	1.47M	1963
Mr. Stephen P. Ewald J.D.	Chief Compliance Officer, General Counsel & Corporate Secretary	914.64k	3.2M	1969
Brandon Ebken	Chief Information Officer	N/A	N/A	N/A
Ms. Lauren Morris	Associate Director of Investors Relations	N/A	N/A	N/A
Mr. Todd Meyers	Vice President of Business Development & Marketing	N/A	N/A	N/A
John T. Wynne MBA	Senior Vice President of Commercial Operations & Clinical Pharmacology Unit	N/A	N/A	N/A
Mr. Reinilde Heyrman M.D.	Chief Medical Officer of Medical Department	N/A	N/A	1961

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate governance

Medpace Holdings, Inc.’s ISS governance QualityScore as of 29 April 2024 is 7. The pillar scores are Audit: 4; Board: 10; Shareholder rights: 8; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.